Respiri Share Price and Company Fundamentals
Last traded: Today at 1:24 AM
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
|Primary activities||e-Health SaaS company supporting respiratory health management.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||432 St Kilda Road Suite 1, Level 9 Melbourne VIC 3004 Australia|
|Phone / Fax||61 3 9653 9160 / 61 3 9822 7735|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Respiri paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RSH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
RSH's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Respiri.
|Mr. Nicholas Smedley||Exec. Chairman||245.46k|
|Mr. Marjan Mikel B.Sc., M.A.I.C.D.||CEO, MD & Exec. Director||451.87k|
|Mr. George Vlachodimitropoulos||Chief Technology Officer||270.33k|
|Mr. Theo Antonopoulos||Chief Commercial Officer||298.57k|
|Ms. Jan P. Barker||Vice-Pres of Bus. Devel.|
|Mr. Andrew Metcalfe CPA||Company Sec.|
|Prof. Noam Gavriely||Medical & Scientific Advisor|
|Mr. Simon Godfrey||Medical & Scientific Advisor|
|Mr. Philippe Ludekens||Gen. Mang. of Commercial Operations|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Respiri is and its enterprise value is .
Companies similar to Respiri (RSH)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Respiri (ASX:RSH) Frequently Asked Questions
1. What is Respiri's Stock Symbol?
Respiri trades on ASX under the ticker symbol "RSH".
2. What is Respiri's stock price today?
One share of RSH stock can currently be purchased for approximately $0.042.
3. How can I contact Respiri?
Respiri's mailing address is 432 St Kilda Road Suite 1, Level 9 Melbourne VIC 3004 Australia. The company can be reached via phone at 61 3 9653 9160.
4. What is Respiri's official website?
The official website of Respiri is https://respiri.co.
5. Which share registry manages Respiri's stock?
Respiri's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.